1. Home
  2. EZPW vs KLRA Comparison

EZPW vs KLRA Comparison

Compare EZPW & KLRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EZCORP Inc. Non Voting

EZPW

EZCORP Inc. Non Voting

HOLD

Current Price

$32.46

Market Cap

2.0B

ML Signal

HOLD

Logo Kailera Therapeutics Inc. Common Stock

KLRA

Kailera Therapeutics Inc. Common Stock

N/A

Current Price

$14.14

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EZPW
KLRA
Founded
1989
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.4B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
EZPW
KLRA
Price
$32.46
$14.14
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$30.67
N/A
AVG Volume (30 Days)
974.7K
745.2K
Earning Date
05-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
29.09
N/A
EPS
1.65
N/A
Revenue
$747,954,000.00
N/A
Revenue This Year
$25.40
N/A
Revenue Next Year
$11.33
N/A
P/E Ratio
$20.04
N/A
Revenue Growth
2.39
N/A
52 Week Low
$16.50
$14.76
52 Week High
$37.13
$23.82

Technical Indicators

Market Signals
Indicator
EZPW
KLRA
Relative Strength Index (RSI) 53.77 35.61
Support Level $31.04 N/A
Resistance Level $36.56 $19.02
Average True Range (ATR) 1.56 1.22
MACD 0.05 -0.16
Stochastic Oscillator 53.28 7.03

Price Performance

Historical Comparison
EZPW
KLRA

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About KLRA Kailera Therapeutics Inc. Common Stock

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

Share on Social Networks: